Research map: EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT

Back to the article

Papers in this map

  1. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment · Helene M. Schoemans · 2018 · 520 citations · Cited by this paper
  2. Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT · Ryszard Swoboda · 2026 · 1 citation · Related
  3. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults · Sonata Jodele · 2014 · 423 citations · Cited by this paper
  4. Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols · 2026 · Related
  5. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury · Sonata Jodele · 2014 · 355 citations · Cited by this paper
  6. Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities · 2026 · Related
  7. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis · Thomas Luft · 2017 · 277 citations · Cited by this paper
  8. Institutional risk management for out-of-specification commercial CAR-T products · 2026 · Related
  9. Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients · Alexandros Spyridonidis · 2020 · 218 citations · Cited by this paper
  10. The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P973–P983) · 2026 · Related
  11. EASIX and mortality after allogeneic stem cell transplantation · Thomas Luft · 2019 · 179 citations · Cited by this paper
  12. Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice · 2026 · Related
  13. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research · Michelle Long Schoettler · 2022 · 148 citations · Cited by this paper
  14. CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy · 2026 · Related
  15. Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy · Narendranath Epperla · 2020 · 97 citations · Cited by this paper
  16. The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards · 2026 · Related
  17. Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD · Markus Zeisbrich · 2017 · 86 citations · Cited by this paper
  18. Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis · 2026 · Related
  19. Cyclosporine A-induced nitration of tyrosine 34 MnSOD in endothelial cells: role of mitochondrial superoxide · Mariano Redondo‐Horcajo · 2010 · 77 citations · Cited by this paper
  20. Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT · 2026 · Related
  21. Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD · Sarah Allison Wall · 2018 · 66 citations · Cited by this paper
  22. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation · Alexandra Pedraza · 2023 · 57 citations · Cited by this paper
  23. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort · Michelle Long Schoettler · 2020 · 55 citations · Cited by this paper
  24. Risk and prognostic factors of transplantation‐associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study · Yishan Ye · 2016 · 45 citations · Cited by this paper
  25. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation · Orsolya N. Horváth · 2018 · 43 citations · Cited by this paper
  26. Thrombotic microangiopathies: An illustrated review · Mouhamed Yazan Abou‐Ismail · 2022 · 43 citations · Cited by this paper
  27. Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation · Eleni Gavriilaki · 2020 · 37 citations · Cited by this paper
  28. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy · Hiroshi Okamura · 2021 · 33 citations · Cited by this paper
  29. Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study · Ang Li · 2020 · 28 citations · Cited by this paper
  30. Reeling in complement in transplant‐associated thrombotic microangiopathy: You're going to need a bigger boat · Sonata Jodele · 2023 · 23 citations · Cited by this paper
  31. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients · Sonata Jodele · 2021 · 21 citations · Cited by this paper
  32. Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis · Silvia Escribano-Serrat · 2023 · 20 citations · Cited by this paper
  33. A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy · Peng Zhao · 2021 · 18 citations · Cited by this paper
  34. Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia · Shu-Qian Tang · 2023 · 18 citations · Cited by this paper
  35. Clinical Outcomes and Treatment Strategies of Adult Transplant‐Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High‐Risk Criteria · Aldo A. Acosta‐Medina · 2025 · 17 citations · Cited by this paper
  36. HLA haploidentical HSCT: from immune imbalance to a platform for immune homeostasis restoration · Huidong Guo · 2025 · 17 citations · Cited by this paper
  37. Thrombotic Microangiopathy: Multi-Institutional Review of Pediatric Patients Who Underwent HSCT · Archana Ramgopal · 2021 · 13 citations · Cited by this paper
  38. High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study · Sumithira Vasu · 2025 · 13 citations · Cited by this paper
  39. CACA guidelines for holistic integrative management of adult acute myeloid leukemia · Hui Wei · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)